stocks index  markets index bulletin investor alert new york markets after hours market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pone way you’re paying creditcard fees even if you don’t have a card ptrump russia and sanctions what we know pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ ptime for gop to face reality everybody is going to have health insurance pbreakingdow industrials just  points shy of  milestone pwhy tax cuts for the rich solve nothing pcigarette maker stocks plunge on fda announcement but health experts are skeptical loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  stockscountryunited states index  markets index bulletin investor alert new york markets after hours market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies location united states name exchange sector  communique laboratory inc ocqlf ootc software  property insurance holdings inc pih xnas nonlife insurance flowerscom inc cl a flws xnas specialty retail pm industries inc opmz ootc food products st capital bank ca fisb ootc banking st constitution bancorp fccy xnas banking st nrg corp fnrc ootc oil extraction st source corp srce xnas banking  motors inc etfm ootc automobiles st century fox inc cl a foxa xnas broadcasting st century fox inc cl b fox xnas broadcasting vianet group inc adr vnet xnas internetonline nd century group inc xxii xase biotechnology  kid doc inc tvmd ootc healthcare provision u inc twou xnas software xleveraged long etracs linked to wells fargo business development co index  bdcl arcx major international banks xleveraged long etracs wells fargo business development lbdc arcx major international banks d eye solutions inc tdey ootc motion picturesound recording d pioneer systems inc dpsm ootc software d systems corp ddd xnys computersconsumer electronics dicon corp tdcp ootc software dshoppingcom thds ootc mixed retailing dx industries inc dddx ootc computersconsumer electronics i group plc adr tgopy ootc finance companies m co mmm xnys diversified holding companies pea international inc tpnl xotc accounting power energy group inc pspw ootc renewable energy generation tl technologies corp ttmzf ootc advertisingmarketingpublic relations  property management inc ftpm ootc real estate agentsbrokers cable tv international inc catv ootc diversified business services licensing corp fourq ootc diversified business services com ltd adr wbai xnys gambling industries job inc adr jobs xnas employmenttraining services com inc adr wuba xnys consumer services barz international inc barz ootc networking n plus inc fplsf ootc commodity chemicals d global technologies inc sixd ootc computer services  renewable energy corp rnwr ootc multiutilities  energy ltd adr tngry ootc oil extraction  holdings plc eihdf ootc gambling industries point energy partners lp cafd xnas renewable energy generation x inc eght xnas wired telecommunications services a clean slate inc drwn ootc diversified business services aw revenue royalties income fund awrrf ootc restaurants a h belo corp series a ahc xnys publishing a schulman inc shlm xnas commodity chemicals a schulman inc  pfd slmnp ootc commodity chemicals ad makepeace co make ootc farming am castle  co cas xnys wholesalers ao smith corp aos xnys building materialsproducts ap moellermaersk as adr amkby ootc water transportshipping ap moellermaersk as series a amkaf ootc water transportshipping ap moellermaersk as series b amkbf ootc water transportshipping as roma spa asraf ootc recreational services a group inc awon ootc tobacco a networks inc aten xnys computer services a milk co ltd acopf ootc biotechnology aac holdings inc aac xnys healthcare provision aac technologies holdings inc aacaf ootc industrial electronics aac technologies holdings inc adr aacay ootc industrial electronics aaon inc aaon xnas building materialsproducts aap inc aapj ootc food products aar corp air xnys aerospace productsparts aarons inc aan xnys consumer services ab science sa abscf ootc pharmaceuticals ab svensk exportkredit elements linked to mlcx biofuels index total return fue arcx finance companies ab svensk exportkredit elements linked to mlcx grain index total return gru arcx finance companies abt financial corp abto ootc banking abacus mining  exploration corp abcff ootc general mining abakan inc abki ootc industrial products abattis bioceuticals corp attbf ootc biotechnology abaxis inc abax xnas medical equipmentsupplies abb ltd ablzf ootc industrial machinery abb ltd adr abb xnys industrial machinery abbott laboratories abt xnys pharmaceuticals abbvie inc abbv xnys biotechnology abby inc abby ootc oil extraction abcam plc abczf ootc biotechnology abcam plc adr abczy ootc biotechnology abco energy inc abce ootc industrial machinery abcourt mines inc abmbf ootc general mining aben resources ltd abnaf ootc general mining abengoa sa b agoaf ootc construction abeona therapeutics inc abeo xnas biotechnology abeona therapeutics inc wt abeow xnas abercrombie  fitch co anf xnys clothing retail aberdeen asiapacific income fund inc fax xase closedend funds aberdeen asiapacific income investment co ltd abakf ootc closedend funds aberdeen asset management plc abdnf ootc investment advisors aberdeen asset management plc adr abdny ootc investment advisors aberdeen australia equity fund inc iaf xase closedend funds aberdeen chile fund inc ch xase closedend funds aberdeen emerging markets smaller company opportunities fund inc abe xase closedend funds aberdeen global income fund inc fco xase closedend funds aberdeen greater china fund inc gch xnys closedend funds aberdeen indonesia fund inc if xase closedend funds aberdeen international inc aabvf ootc general mining aberdeen israel fund inc isl xase closedend funds aberdeen japan equity fund inc jeq xnys closedend funds aberdeen latin america equity fund inc laq xase closedend funds aberdeen singapore fund inc sgf xnys closedend funds abertis infraestructuras sa adr abrty ootc transportation services ability inc abil xnas precision products ability inc wt abiwf ootc abiomed inc abmd xnas medical equipmentsupplies abitibi royalties inc atbyf ootc general mining able energy inc able ootc gas utilities ablynx nv ablyf ootc biotechnology abm industries inc abm xnys diversified business services abraxas petroleum corp axas xnas oil extraction absecon bancorp ascn ootc banking absolute health  fitness inc ahfi ootc recreational services absolute software corp alswf ootc software abt holdings inc abot ootc precious metals abtech holdings inc abhd ootc industrial machinery abv consulting inc abvn ootc advertisingmarketingpublic relations ac immune sa aciu xnas biotechnology acacia communications inc acia xnas networking acacia diversified holdings inc acca ootc specialty retail acacia mining plc abglf ootc gold acacia research corp  acacia technologies actg xnas diversified business services acadia healthcare co inc achc xnas healthcare provision acadia pharmaceuticals inc acad xnas biotechnology acadia realty trust akr xnys acadian timber corp acazf ootc forestry  wood products acasti pharma inc acst xnas pharmaceuticals accelera innovations inc acnv ootc healthcare provision accelerate diagnostics inc axdx xnas biotechnology accelerize inc aclz xotc life insurance acceleron pharma inc xlrn xnas biotechnology accenture plc cl a acn xnys diversified business services access national corp ancx xnas banking access power inc accr ootc wired telecommunications services access worldwide communications inc awwc ootc advertisingmarketingpublic relations acciona sa acxif ootc construction acco brands corp acco xnys nondurable household products accor sa acrff ootc hotels accor sa adr accyy ootc hotels accordia golf co ltd acgff ootc recreational services accredited mortgage loan reit trust  perp cum pfd series a ahhap ootc mortgages accretive health inc achi ootc healthcare provision accuray inc aray xnas medical equipmentsupplies accuride corp acw xnys auto  commercial vehicle parts acelrx pharmaceuticals inc acrx xnas pharmaceuticals acer inc gdr reg s aceyy ootc computersconsumer electronics acerus pharmaceuticals corp trlpf ootc biotechnology aceto corp acet xnas specialty chemicals achaogen inc akao xnas biotechnology achillion pharmaceuticals inc achn xnas biotechnology aci worldwide inc aciw xnas software «» log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pone way you’re paying creditcard fees even if you don’t have a card ptrump russia and sanctions what we know pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ ptime for gop to face reality everybody is going to have health insurance pbreakingdow industrials just  points shy of  milestone pwhy tax cuts for the rich solve nothing pcigarette maker stocks plunge on fda announcement but health experts are skeptical loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  sorrento therapeutics inc  product pipeline review    compare about us  contact us home research category publisher list custom research cart compare research category user guide policies contact us about us site map home  market research report  pharmaceutical  pharmaceutical companies market research report sorrento therapeutics inc  product pipeline review   published by global markets direct product code  published june   content info  pages price usd  pdf by email single user license usd  pdf by email site license usd  pdf by email global license sorrento therapeutics inc  product pipeline review   published june   content info  pages description summary global markets directs sorrento therapeutics inc  product pipeline review   provides an overview of the sorrento therapeutics incs pharmaceutical research and development focus the report provides comprehensive information on the therapeutics under development by sorrento therapeutics inc complete with analysis by stage of development drug target mechanism of action moa route of administration roa and molecule type the report also covers the descriptive pharmacological action of the therapeutics its complete research and development history and the dormant and discontinued projects global markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites clinical trial registries conferences sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information additionally various dynamic tracking processes ensure that the most recent developments are captured on a real time basis the report helps in identifying and tracking emerging players in the market and their portfolios enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage note certain sections in the report may be removed or altered based on the availability and relevance of data scope the report provides a snapshot of the pipeline therapeutic landscape of sorrento therapeutics inc the report provides overview of sorrento therapeutics inc including its business description key facts and locations and subsidiaries the report features descriptive drug profiles for the pipeline products which includes product description descriptive moa rd brief licensing and collaboration details  other developmental activities the report covers pipeline products based on various stages of development ranging from preregistration till discovery and undisclosed stages the report assesses sorrento therapeutics incs pipeline therapeutics based on drug target mechanism of action moa route of administration roa and molecule type the report features sorrento therapeutics incs outlicensed and partnered product portfolio and summarizes its dormant and discontinued projects reasons to buy evaluate sorrento therapeutics incs strategic position with total access to detailed information on its product pipeline gain strategically significant competitor information analysis and insights to formulate effective rd strategies identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage identify and understand important and diverse types of therapeutics under development for sorrento therapeutics inc identify potential new clients or partners in the target demographic plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics devise corrective measures for pipeline projects by understanding sorrento therapeutics incs pipeline depth and focus of pipeline therapeutics develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope table of contents product code gmdhccdb table of contents table of contents list of tables list of figures sorrento therapeutics inc snapshot sorrento therapeutics inc overview key information key facts sorrento therapeutics inc  research and development overview key therapeutic areas sorrento therapeutics inc  pipeline review pipeline products by stage of development pipeline products  monotherapy pipeline products  partnered products partnered productscombination treatment modalities sorrento therapeutics inc  pipeline products glance sorrento therapeutics inc  clinical stage pipeline products phase ii productscombination treatment modalities phase i productscombination treatment modalities sorrento therapeutics inc  early stage pipeline products preclinical productscombination treatment modalities discovery productscombination treatment modalities sorrento therapeutics inc  drug profiles cellular immunotherapy to target cea for oncology product description mechanism of action rd progress cellular immunotherapy to target pdl for oncology product description mechanism of action rd progress cellular immunotherapy to target psma for prostate cancer product description mechanism of action rd progress ba product description mechanism of action rd progress cba product description mechanism of action rd progress cellular immunotherapy to target ckit for solid tumors product description mechanism of action rd progress cellular immunotherapy to target cd for acute myeloid leukemia product description mechanism of action rd progress cellular immunotherapy to target cd for acute myeloid leukemia product description mechanism of action rd progress cellular immunotherapy to target gd for solid tumors product description mechanism of action rd progress cellular immunotherapy to target her for glioblastoma product description mechanism of action rd progress cellular immunotherapy to target her for oncology product description mechanism of action rd progress cellular immunotherapy to target ilr alpha for glioblastoma multiforme product description mechanism of action rd progress cellular immunotherapy to target muc for ovarian cancer product description mechanism of action rd progress cellular immunotherapy to target ror for solid tumor product description mechanism of action rd progress monoclonal antibody to inhibit cd for oncology product description mechanism of action rd progress monoclonal antibody to inhibit ghrelin for obesity product description mechanism of action rd progress monoclonal antibody to target egfr and inhibit pdl for oncology product description mechanism of action rd progress rituximab biosimilar product description mechanism of action rd progress small molecules to inhibit cmyc for solid tumors and hematological malignancies product description mechanism of action rd progress sti product description mechanism of action rd progress stia product description mechanism of action rd progress stia product description mechanism of action rd progress stia product description mechanism of action rd progress stia product description mechanism of action rd progress stia product description mechanism of action rd progress stia product description mechanism of action rd progress stib product description mechanism of action rd progress stic product description mechanism of action rd progress stid product description mechanism of action rd progress bc product description mechanism of action rd progress clostridium difficile vaccine product description mechanism of action rd progress monoclonal antibodies for clostridium difficile product description mechanism of action rd progress monoclonal antibodies for hepatitis c product description mechanism of action rd progress monoclonal antibodies to inhibit wisp for idiopathic pulmonary fibrosis product description mechanism of action rd progress sti product description mechanism of action rd progress sorrento therapeutics inc  pipeline analysis sorrento therapeutics inc  pipeline products by target sorrento therapeutics inc  pipeline products by route of administration sorrento therapeutics inc  pipeline products by molecule type sorrento therapeutics inc  pipeline products by mechanism of action sorrento therapeutics inc  recent pipeline updates sorrento therapeutics inc  dormant projects sorrento therapeutics inc  discontinued pipeline products discontinued pipeline product profiles paclitaxel sorrento therapeutics inc  locations and subsidiaries head office other locations  subsidiaries appendix methodology coverage secondary research primary research expert panel validation contact us disclaimer list of tables sorrento therapeutics inc key information sorrento therapeutics inc key facts sorrento therapeutics inc  pipeline by indication  sorrento therapeutics inc  pipeline by stage of development  sorrento therapeutics inc  monotherapy products in pipeline  sorrento therapeutics inc  partnered products in pipeline  sorrento therapeutics inc  partnered products combination treatment modalities  sorrento therapeutics inc  phase ii  sorrento therapeutics inc  phase i  sorrento therapeutics inc  preclinical  sorrento therapeutics inc  discovery  sorrento therapeutics inc  pipeline by target  sorrento therapeutics inc  pipeline by route of administration  sorrento therapeutics inc  pipeline by molecule type  sorrento therapeutics inc  pipeline products by mechanism of action  sorrento therapeutics inc  recent pipeline updates  sorrento therapeutics inc  dormant developmental projects sorrento therapeutics inc  discontinued pipeline products  sorrento therapeutics inc subsidiaries list of figures sorrento therapeutics inc  pipeline by top  indication  sorrento therapeutics inc  pipeline by stage of development  sorrento therapeutics inc  monotherapy products in pipeline  sorrento therapeutics inc  partnered products in pipeline  sorrento therapeutics inc  pipeline by top  target  sorrento therapeutics inc  pipeline by top  molecule type  sorrento therapeutics inc  pipeline products by top  mechanism of action  phone intl  tollfreeus  europe  asia  new for   gii now purchases any market research reports from any publishers for you with noextra cost contact us for more details faq delivery time user license payment options compare multiple reports about contact user guide policies site map  copyright  global information inc all rights reserved stocks index  markets index bulletin investor alert new york markets after hours market snapshot winners and losers stocks rates funds bonds benchmarks real estate investment trusts futures american depository receipt stocks exchange traded notes warrants indexes exchange traded funds currencies crypto currencies browse stocks stocks az abcdefghijklmnopqrstuvwxyzother browse by location argentina australia austria bahamas bahrain belgium bermuda botswana brazil british virgin islands canada cayman islands chile china colombia curacao cyprus czech republic denmark egypt estonia finland france germany gibraltar greece hong kong hungary iceland india indonesia ireland isle of man israel italy japan jordan kazakhstan kuwait latvia lebanon liechtenstein lithuania luxembourg malaysia malta mauritius mexico monaco money rates morocco namibia netherlands new zealand norway oman pakistan panama peru philippines poland portugal qatar romania russia saudi arabia singapore slovakia slovenia south africa south korea spain sri lanka sweden switzerland taiwan thailand tunisia turkey ukraine united arab emirates united states venezuela western samoa log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pone way you’re paying creditcard fees even if you don’t have a card ptrump russia and sanctions what we know pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ ptime for gop to face reality everybody is going to have health insurance pbreakingdow industrials just  points shy of  milestone pwhy tax cuts for the rich solve nothing pcigarette maker stocks plunge on fda announcement but health experts are skeptical loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft srne stock price  sorrento therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p updated longdated treasury yields see weekly climb p updated sp  nasdaq finish lower after amazon disappointment dow closes at record p updated the highest paid athletes in the world in one chart p updated how to raise your kids to be frugal but not too frugal p updated cities to move to if you want to work in tech — not including san francisco p updated what donald trump’s battle of wills with jeff sessions teaches you about a difficult boss p trump russia and sanctions what we know p updated one way you’re paying creditcard fees even if you don’t have a card p updated this is the worst mistake people make at work to be replaced home investing quotes stocks united states srne overview compare quotes stock screener earnings calendar sectors nasdaq srne us nasdaq join td ameritrade find a broker sorrento therapeutics inc watchlist createsrnealert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones sorrentos stock plunges on heavy volume after stock offering prices at deep discount apr   at  am et by tomi kilgore sorrento therapeutics stock plunges  after share offering priced at deep discount apr   at  am et by tomi kilgore six stocks to watch jul   at  pm et by harry boxer nasdaq composite nails the breakout point jun   at  am et by michael ashbaugh  stocks to watch jun   at  pm et by harry boxer  stocks to watch mar   at  pm et by harry boxer celgene shows savvy as gilead keeps backsliding mar   at  am et on barrons new force on wall street the ‘family office’ mar   at  pm et on the wall street journal cfo moves fidelity investments universal truckload services sorrento therapeutics apr   at  pm et on the wall street journal cfo moves dream office real estate investment trust sorrento therapeutics seek jun   at  pm et on the wall street journal an asco primer which drug makers are pursuing which kinds of therapies may   at  pm et on the wall street journal sorrento reaches collaboration deal valued at  million mar   at  am et on the wall street journal cfo moves brown shoe company unum group sorrento therapeutics feb   at  pm et on the wall street journal stocks to watch walmart gentiva cisco may   at  am et on the wall street journal recent news other news press releases fda oks sorrentos ind for nonopioid pain candidate resiniferatoxin clinical trial in cancer pain planned shares up  fda oks sorrentos ind for nonopioid pain candidate resiniferatoxin clinical trial in cancer pain planned shares up  jun   at  pm et on seeking alpha sorrento continues rally up  sorrento continues rally up  jun   at  am et on seeking alpha premarket gainers as of  am premarket gainers as of  am jun   at  am et on seeking alpha q sorrento therapeutics inc q sorrento therapeutics inc may   at  pm et on edgar online  edg  q k week in review ping an announces  billion fintechhealthcare vc fund week in review ping an announces  billion fintechhealthcare vc fund may   at  pm et on seeking alpha sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service business sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service business may   at  am et on cnw group marriott international inc mar leads  notable investor filings marriott international inc mar leads  notable investor filings may   at  pm et on investorplacecom insiderinsightscom daily round up  tcbi glv glo glq apr   at  pm et on seeking alpha premarket gainers as of  am apr   at  am et on seeking alpha insiderinsightscom daily round up  wfc merc virt glo dkl apr   at  am et on seeking alpha sorrentos anticea cart candidate shows treatment effect in cea liver cancer patients but survival benefit barely ahead of bayers stivarga and bsc shares ease  apr   at  pm et on seeking alpha k sorrento therapeutics inc mar   at  am et on edgar online  edg  q k celgene shows savvy as gilead keeps backsliding mar   at  am et on barrons new force on wall street the ‘family office’ mar   at  pm et on the wall street journal insider buys shares of sorrento therapeutics feb   at  am et on gurufocuscom hottest services stocks now – ccih fncx llnw matr dec   at  am et on investorplacecom immunotherapy bearish overreaction can create opportunity dec   at  am et on seeking alpha hottest services stocks now – qnst casc fve gvp dec   at  pm et on investorplacecom hottest services stocks now – hmny tgh slp cai dec   at  pm et on investorplacecom biggest movers in services stocks now – vrtu rcii twtr asur dec   at  pm et on investorplacecom todays research reports on stocks to watch sorrento therapeutics and omeros corporation todays research reports on stocks to watch sorrento therapeutics and omeros corporation jul   at  am et on accesswire sorrento therapeutics announced fda authorization of ind to commence clinical trial of rtx in intractable cancer pain sorrento therapeutics announced fda authorization of ind to commence clinical trial of rtx in intractable cancer pain jun   at  pm et on pr newswire  prf semnur pharmaceuticals inc announces successful phase    trial in patients with radicular pain for its lead product sp semnur pharmaceuticals inc announces successful phase    trial in patients with radicular pain for its lead product sp jun   at  am et on pr newswire  prf loncar cancer immunotherapy index conducts semiannual rebalance loncar cancer immunotherapy index conducts semiannual rebalance jun   at  am et on businesswire  bzx sorrento therapeutics announces dismissal of lawsuits sorrento therapeutics announces dismissal of lawsuits jun   at  pm et on pr newswire  prf sorrento therapeutics pain subsidiary scilex pharmaceuticals announces positive data from head to head adhesion study with its lead product ztlido™ sorrento therapeutics pain subsidiary scilex pharmaceuticals announces positive data from head to head adhesion study with its lead product ztlido™ jun   at  am et on pr newswire  prf sorrento therapeutics contributes to the formation of celularity inc sorrento therapeutics contributes to the formation of celularity inc jun   at  am et on pr newswire  prf technical insights on biotech stocks  soligenix sorrento therapeutics alcobra and akebia therapeutics technical insights on biotech stocks  soligenix sorrento therapeutics alcobra and akebia therapeutics jun   at  am et on pr newswire  prf sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service business sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service business may   at  am et on pr newswire  prf sorrento therapeutics announces closing of its acquisition of virttu biologics apr   at  am et on pr newswire  prf sorrento announces closing of public offering of common stock apr   at  pm et on pr newswire  prf sorrento announces pricing of public offering of common stock apr   at  am et on pr newswire  prf sorrento announces proposed public offering of common stock apr   at  pm et on pr newswire  prf global tcell immunotherapy pipeline analysis   clinical trials  results patent designation collaboration and other developments apr   at  pm et on pr newswire  prf sorrento therapeutics anticea cart demonstrates promising clinical activity and safety in phase ib clinical trial apr   at  pm et on pr newswire  prf sorrento and wildcat announce resolution mar   at  am et on pr newswire  prf sorrento therapeutics to present at th annual roth conference mar   at  pm et on pr newswire  prf the life sciences report examines the inclusion of sorrento therapeutics on streetwise reports  smallcap biotech watchlist jan   at  am et on marketwired sorrento subsidiary scilex pharmaceuticals announces key endpoints met in the european union pivotal bioequivalence clinical study for its lead product ztlido™ jan   at  am et on pr newswire  prf loncar cancer immunotherapy index conducts semiannual rebalance dec   at  am et on businesswire  bzx sorrento therapeutics inc sorrento therapeutics inc engages in the research development and manufacture of biopharmaceutical products it focuses on therapies to treat specific stages in the evolution of cancer from elimination to equilibrium and escape which include biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies and antibody drug conjugates the company was founded by henry h ji in  and is headquartered in san diego ca see full profile benzingas top initiations oct   at  am et on benzingacom benzingas top initiations dec   at  am et on benzingacom benzingas top initiations may   at  am et on benzingacom competitors name chg  market cap exelixis inc  b sucampo pharmaceuticals inc cl a  m synergy pharmaceuticals inc  m karyopharm therapeutics inc  m competitor data provided by partner content trending tickers powered by dvax  mo  aks  ssti  fl  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience company  sorrento therapeutics careers contact company sorrento is an antibodycentric clinical stage biopharmaceutical company developing new treatments for cancer inflammation and autoimmune diseases sorrento’s lead products are multiple latestage biosimilar and biobetter antibodies as well as clinical cart therapies targeting solid tumors sorrento has a portfolio of preclinical immunooncology antibody programs and antibody drug conjugates adcs through our subsidiary tnk therapeutics we are developing adoptive immunotherapies utilizing t cell as well as natural killer nk cell  sorrento’s joint venture company la cell is developing cellinternalizing mabs against undruggable intracellular targets menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact sorrento therapeutics  next generation targeted  personalized careers contact ontarget people passion and innovation drive our scientific team » ontarget facility our new stateoftheart research and manufacturing facility » ontarget leadership bold vision and strategic execution » biosimilars immunooncologyantibodies cellulartherapy cellinternalizingantibodies antibodydrugconjugates menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact stock information  sorrento therapeutics careers contact stock information sorrento therapeutics inc trades under the symbol nasdaq srne download irs form  – click here menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact our mission  sorrento therapeutics careers contact our mission our mission is to address unmet medical needs by developing novel immunotherapies against medicallyrelevant targets irrespective of their location ie extracellular intracellular or membranebound antigens utilizing sorrento’s unique portfolio of proprietary ontarget antibody technologies sorrento is an antibodycentric clinical stage biopharmaceutical company focused on the discovery and development of safe and effective immunotherapies for oncology and autoimmuneinflammation diseases sorrento’s lead programs consist of four phase iii biosimilarbiobetter antibodies which address an established market of more than  billion and two phase i cart programs for treatment of solid tumors sorrento also is advancing a portfolio of adoptive cellular therapies immunooncology mabs and antibody drug conjugates adcs sorrento partnered with city of hope to form la cell subsidiary to focus on developing cellinternalizing mabs against undruggable intracellular targets “we believe our unique portfolio of ontarget immunotherapies is unrivaled in the industry it includes intracellular antibodies immune checkpoint inhibitors bispecific antibodies antibodydrug conjugates adcs as well as chimeric antigen receptor carbased cellular therapies” – ceo dr henry ji menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact careers  sorrento therapeutics careers contact careers sorrento therapeutics inc is an equal opportunity employer and offers an attractive salary and comprehensive benefits package that includes stock options medical dental life and disability insurance k and paid holidays   powered by menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact sorrento therapeutics  next generation targeted  personalized careers contact ontarget people passion and innovation drive our scientific team » ontarget facility our new stateoftheart research and manufacturing facility » ontarget leadership bold vision and strategic execution » biosimilars immunooncologyantibodies cellulartherapy cellinternalizingantibodies antibodydrugconjugates menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact contact  sorrento therapeutics careers contact contact sorrento therapeutics inc  directors place san diego ca  tel   fax   infosorrentotherapeuticscom clinical trials clinicaltrialssorrentotherapeuticscom investors investorssorrentotherapeuticscom business development businesssorrentotherapeuticscom our new  sf corporate headquarters has been completely modernized to a stateoftheart facility for the sorrento scientists and administrative team we have created  sf of rd laboratory space and  sf of cgmp laboratory space is currently under construction menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact sorrento therapeutics  next generation targeted  personalized careers contact ontarget people passion and innovation drive our scientific team » ontarget facility our new stateoftheart research and manufacturing facility » ontarget leadership bold vision and strategic execution » biosimilars immunooncologyantibodies cellulartherapy cellinternalizingantibodies antibodydrugconjugates menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact sorrento therapeutics inc  directors pl san diego ca pharmaceutical productswholesale  mapquest sorrento therapeutics inc  directors pl san diego ca  reviews   website menu  reservations make reservations order online tickets tickets see availability nearby directions  date name shares transaction value  henry h ji president and ceo director    acquisition at  per share   ally bridge group hk ltd    acquisition at  per share   ally bridge group hk ltd    acquisition at  per share   henry h ji president and ceo director    acquisition at  per share   henry h ji president and ceo director    acquisition at  per share   jaisim shah director    acquisition at  per share   jeffrey su executive vp and coo    acquisition at  per share   jerome b zeldis see remarks    acquisition at  per share   kevin m herde executive vp and cfo    acquisition at  per share   yue wu director    acquisition at  per share   kim d janda director    acquisition at  per share   george k ng see remarks    disposition at  per share   ally bridge group hk ltd      ally bridge group hk ltd      ally bridge group hk ltd      henry h ji president and ceo director    award at  per share   george k ng see remarks    award at  per share   patrick soonshiong    disposition at  per share   patrick soonshiong    disposition at  per share   patrick soonshiong    disposition at  per share  newslatestcompanyussrne marketwatch news on srne sorrentos stock plunges on heavy volume after stock offering prices at deep discount  am april    tomi kilgore sorrento therapeutics stock plunges  after share offering priced at deep discount  am april    tomi kilgore six stocks to watch  pm july    the trading deck nasdaq composite nails the breakout point  am june    michael ashbaugh  stocks to watch  pm june    the trading deck  stocks to watch  pm march    the trading deck newsnonmarketwatchcompanyussrne other news on srne fda oks sorrentos ind for nonopioid pain candidate resiniferatoxin clinical trial in cancer pain planned shares up   pm june    seeking alpha sorrento continues rally up   am june    seeking alpha premarket gainers as of  am  am june    seeking alpha q sorrento therapeutics inc  pm may    edgar online  edg  q k week in review ping an announces  billion fintechhealthcare vc fund  pm may    seeking alpha marriott international inc mar leads  notable investor filings  pm may    investorplacecom insiderinsightscom daily round up  tcbi glv glo glq  pm april    seeking alpha premarket gainers as of  am  am april    seeking alpha insiderinsightscom daily round up  wfc merc virt glo dkl  am april    seeking alpha sorrentos anticea cart candidate shows treatment effect in cea liver cancer patients but survival benefit barely ahead of bayers stivarga and bsc shares ease   pm april    seeking alpha k sorrento therapeutics inc  am march    edgar online  edg  q k celgene shows savvy as gilead keeps backsliding  am march    barronscom new force on wall street the ‘family office’  pm march    the wall street journal interactive edition insider buys shares of sorrento therapeutics  pm feb    gurufocuscom hottest services stocks now – ccih fncx llnw matr  pm dec    investorplacecom immunotherapy bearish overreaction can create opportunity  am dec    seeking alpha hottest services stocks now – qnst casc fve gvp  pm dec    investorplacecom hottest services stocks now – hmny tgh slp cai  pm dec    investorplacecom biggest movers in services stocks now – vrtu rcii twtr asur  pm dec    investorplacecom scilex pharmas ztlido matches lidoderm in comparative study nda on tap for mid  am dec    seeking alpha loading more headlines at a glance sorrento therapeutics inc  directors place san diego california  phone   industry biotechnology sector health carelife sciences fiscal yearend  view sec filings revenue m net income m  sales growth  employees  annual report for srne newspressreleasecompanyussrne press releases on srne todays research reports on stocks to watch sorrento therapeutics and omeros corporation  am july    accesswire sorrento therapeutics announced fda authorization of ind to commence clinical trial of rtx in intractable cancer pain  pm june    pr newswire  prf semnur pharmaceuticals inc announces successful phase    trial in patients with radicular pain for its lead product sp  am june    pr newswire  prf loncar cancer immunotherapy index conducts semiannual rebalance  am june    businesswire  bzx sorrento therapeutics announces dismissal of lawsuits  pm june    pr newswire  prf sorrento therapeutics pain subsidiary scilex pharmaceuticals announces positive data from head to head adhesion study with its lead product ztlido™  am june    pr newswire  prf sorrento therapeutics contributes to the formation of celularity inc  am june    pr newswire  prf technical insights on biotech stocks  soligenix sorrento therapeutics alcobra and akebia therapeutics  am june    pr newswire  prf sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service business  am may    pr newswire  prf sorrento therapeutics announces closing of its acquisition of virttu biologics  am april    pr newswire  prf sorrento announces closing of public offering of common stock  pm april    pr newswire  prf sorrento announces pricing of public offering of common stock  am april    pr newswire  prf sorrento announces proposed public offering of common stock  pm april    pr newswire  prf global tcell immunotherapy pipeline analysis   clinical trials  results patent designation collaboration and other developments  pm april    pr newswire  prf sorrento therapeutics anticea cart demonstrates promising clinical activity and safety in phase ib clinical trial  pm april    pr newswire  prf sorrento and wildcat announce resolution  am march    pr newswire  prf sorrento therapeutics to present at th annual roth conference  pm march    pr newswire  prf the life sciences report examines the inclusion of sorrento therapeutics on streetwise reports  smallcap biotech watchlist  am jan    marketwired sorrento subsidiary scilex pharmaceuticals announces key endpoints met in the european union pivotal bioequivalence clinical study for its lead product ztlido™  am jan    pr newswire  prf loncar cancer immunotherapy index conducts semiannual rebalance  am dec    businesswire  bzx loading more headlines trending tickers quoteszigmancomposite vuzi quoteszigmancomposite jcp quoteszigmancomposite nugt quoteszigmancomposite jnug quoteszigmancomposite tlt x powered by log in  pm edt july   marketstatecountryus new york after marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials plongdated treasury yields see weekly climb psp  nasdaq finish lower after amazon disappointment dow closes at record pthe highest paid athletes in the world in one chart phow to raise your kids to be frugal but not too frugal pcities to move to if you want to work in tech — not including san francisco pwhat donald trump’s battle of wills with jeff sessions teaches you about a difficult boss pone way you’re paying creditcard fees even if you don’t have a card ptrump russia and sanctions what we know pthis is the worst mistake people make at work pmove over breathalyzers ‘textalyzers’ could be used on drivers’ phones pjared kushner’s unorthodox approach to meetings is a cautionary tale for office workers everywhere phere’s how much you should spend on a yoga mat p weird things i found out about america in my first  hours pweekend sip is this the world’s first distilled nonalcoholic spirit pgoodyear stock stumbles  after quarter ‘played out differently than we expected’ ptime for gop to face reality everybody is going to have health insurance pbreakingdow industrials just  points shy of  milestone pwhy tax cuts for the rich solve nothing pcigarette maker stocks plunge on fda announcement but health experts are skeptical loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  sorrento therapeutics inc  product pipeline review   sorrento therapeutics inc  product pipeline review   dec    et from reportlinker new york dec   prnewswire  sorrento therapeutics inc  product pipeline review  summaryglobal markets directs sorrento therapeutics inc  product pipeline review   provides an overview of the sorrento therapeutics incs pharmaceutical research and development focusthis report provides comprehensive information on the current therapeutic developmental pipeline of sorrento therapeutics incs complete with comparative analysis at various stages therapeutics assessment by drug target mechanism of action moa route of administration roa and molecule type it also reviews latest updates and featured news and press releases along with special features on latestage and discontinued projectsglobal markets directs report features investigational drugs from across globe covering over  therapy areas and nearly  indications the report is built using data and information sourced from global markets directs proprietary databases companyuniversity websites sec filings investor presentations and featured press releases from companyuniversity sites and industryspecific third party sources put together by global markets directs team drug profilesrecords featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information additionally processes including live news  deals tracking browser based alertbox and clinical trials registries tracking ensure that the most recent developments are captured on a real time basisthe report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage it strengthens rd pipelines by identifying new targets and moas to produce firstinclass and bestinclass productsnote certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated diseasescope the report provides brief overview of sorrento therapeutics inc including business description key information and facts and its locations and subsidiaries the report reviews current pipeline of sorrento therapeutics incs human therapeutic division and enlists all their major and minor projects the report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones  special feature on outlicensed and partnered product portfolio the report summarizes all the dormant and discontinued pipeline projects latest company statement  latest news and deals relating to the sorrento therapeutics incs pipeline productsreasons to buy evaluate sorrento therapeutics incs strategic position with total access to detailed information on its product pipeline assess the growth potential of sorrento therapeutics inc in its therapy areas of focus identify new drug targets and therapeutic classes in the sorrento therapeutics incs rd portfolio and develop key strategic initiatives to reinforce pipeline in those areas exploit inlicensing opportunities by identifying windows of opportunity to fill portfolio gaps develop strategic initiatives by understanding the focus areas of sorrento therapeutics inc and exploit collaboration and partnership opportunities identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage plan mergers and acquisitions effectively by identifying the most promising pipeline of sorrento therapeutics inc develop and design inlicensing and outlicensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope explore the dormant and discontinued projects of sorrento therapeutics inc and identify potential opportunities in those areas avoid intellectual property rights related issuesread the full report httpwwwreportlinkercompsummaryviewreporthtmlabout reportlinker reportlinker is an awardwinning market research solution that finds filters and organizes the latest industry data so you get all the market research you need  instantly in one placehttpwwwreportlinkercom contact clare clarereportlinkercom us intl   source reportlinker related links httpwwwreportlinkercom view table fullscreen view table fullscreen journalists and bloggers the news you need when you need it join pr newswire for journalists to access all of the free services designated to make your job easier in need of subject matter experts for your story submit a free profnet request and find the sources you need learn more my news release contains wide tables view fullscreen read more jul    et global colorectal cancer partnering  to  jul    et global organic acid market by type acetic acid citric acid jul    et pharmacy automation market by product packaging  labeling looking to send a news release with pr newswire take advantage of the worlds leading distribution platform sign up to get started request more information have an account log in search searching for your content advanced search facebook autocomplete demo post a rating  month price target   home trending sign up log in analyst ranking   name measured ratings sucess rate avg return  mizuho      credit suisse      jefferies      cantor fitzgerald      bank of america merrill lynch      jmp securities      goldman sachs      raymond james      fbr capital markets      william blair     news releases  sorrento therapeutics careers contact news releases sorrento therapeutics announced fda authorization of ind to commence clinical trial of rtx in intractable cancer painjune  sorrento therapeutics announces dismissal of lawsuitsjune  sorrento therapeutics pain subsidiary scilex pharmaceuticals announces positive data from head to head adhesion study with its lead product ztlido™june  sorrento therapeutics contributes to the formation of celularity incjune  sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service businessmay  sorrento therapeutics announces closing of its acquisition of virttu biologicsapril  sorrento announces closing of public offering of common stockapril  sorrento announces pricing of public offering of common stockapril  sorrento announces proposed public offering of common stockapril  sorrento therapeutics anticea cart demonstrates promising clinical activity and safety in phase ib clinical trialapril  sorrento and wildcat announce resolutionmarch  sorrento therapeutics to present at th annual roth conferencemarch  sorrento subsidiary scilex pharmaceuticals announces key endpoints met in the european union pivotal bioequivalence clinical study for its lead product ztlido™january  sorrento subsidiary scilex pharmaceuticals announces key endpoints met in pivotal bioequivalence clinical study for its lead product ztlido™december  sorrentos tnk therapeutics provides progress update for its anticd and cd cart programs for treatment of hematological malignanciesdecember  sorrento therapeutics inc secures  million loan facilitynovember  sorrentos tnk therapeutics subsidiary to acquire virttu biologicsnovember  sorrento therapeutics to attend jefferies and roth investor conferencesnovember  sorrento therapeutics closes acquisition of scilexnovember  ark animal health a subsidiary of sorrento therapeutics announces submission of two major technical sections of a new animal drug applicationseptember  sorrento appoints miranda toledano as executive vice president of corporate development and president of la cellseptember  sorrento therapeutics to present at two upcoming conferences in new york cityaugust  scintilla pharmaceuticals inc a subsidiary of sorrento therapeutics inc to acquire semnur pharmaceuticals inc to further deepen its pain management pipelineaugust  dr jerome zeldis md phd former chief medical officer of celgene to join sorrento as chief medical officer and president of clinical developmentaugust  scintilla pharmaceuticals a subsidiary of sorrento therapeutics to acquire scilex pharmaceuticals to add a latestage asset to bolster its pain management businessaugust  sorrento to form joint venture with cha biotech to develop and commercialize natural killer cell therapiesaugust  sorrento therapeutics announces the appointment of dr yue alexander wu to its board of directorsaugust  sorrento and servier enter into exclusive worldwide license and collaboration agreement for development and commercialization of antipd antibodyjuly  sorrento closes  million private placement investmentsjune  sorrento and sbio announce cart joint venture in chinajune  sorrento therapeutics to present at the jefferies  healthcare conferencemay  sorrento announces positive data from a combined phase    clinical study of sti an antiige biosimilar antibodymay  sorrento therapeutics engaged advisors for exploring strategic alternativesmay  sorrento closes private placement with yuhan corporationmay  sorrento to present at  upcoming conferences in new york citymay  sorrento to present at the upcoming american association for cancer research aacr annual meetingapril  sorrento to present at the jefferies immunooncology summitapril  sorrento appoints kevin m herde as chief financial officerapril  sorrento announces definitive agreements for up to  million private placementapril   menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact srne stock price  sorrento therapeutics inc stock quote us nasdaq  marketwatch sections watchlist signup • login search bulletin us europe asia fx rates futures range d d m m m y y dow    sp     nasdaq    globaldow    gold    oil    sp  movers algn  mhk  col  lyb  fls  mo  sbux  gt  latest newsall times eastern p updated wall street isn’t ready for a point tumble in the dow industrials p updated longdated treasury yields see weekly climb p updated sp  nasdaq finish lower after amazon disappointment dow closes at record p updated the highest paid athletes in the world in one chart p updated how to raise your kids to be frugal but not too frugal p updated cities to move to if you want to work in tech — not including san francisco p updated what donald trump’s battle of wills with jeff sessions teaches you about a difficult boss p trump russia and sanctions what we know p updated one way you’re paying creditcard fees even if you don’t have a card p updated this is the worst mistake people make at work to be replaced home investing quotes stocks united states srne overview compare quotes stock screener earnings calendar sectors nasdaq srne us nasdaq join td ameritrade find a broker sorrento therapeutics inc watchlist createsrnealert after hours last updated jul    pm edt delayed quote     after hours volume k close chg chg     advanced charting d d m m m ytd y y all   vol advanced charting  vs avg volume k  day avg  m open  close   day lowhigh  day range   week lowhigh  your watchlist customize marketwatch have watchlists log in to see them here or sign up to get started create account … or log in symbol last chg chg  no items in watchlist there are currently no items in this watchlist add ticker to watchlist go to your watchlist no saved watchlists create a list of the investments you want to track create watchlist …or try this starter list uh oh something went wrong while loading watchlist go to watchlist recently viewed tickers no recent tickers visit a quote page and your recently viewed tickers will be displayed here search tickers overview profile news charts financials historical quotes analyst estimates options sec filings insiders key data open  day range     week range    market cap m shares outstanding m public float m beta  rev per employee k pe ratio na eps  yield na dividend na exdividend date na short interest m   of float shorted  average volume m performance  day   month   month  ytd   year  recent news marketwatch other dow jones sorrentos stock plunges on heavy volume after stock offering prices at deep discount apr   at  am et by tomi kilgore sorrento therapeutics stock plunges  after share offering priced at deep discount apr   at  am et by tomi kilgore six stocks to watch jul   at  pm et by harry boxer nasdaq composite nails the breakout point jun   at  am et by michael ashbaugh  stocks to watch jun   at  pm et by harry boxer  stocks to watch mar   at  pm et by harry boxer celgene shows savvy as gilead keeps backsliding mar   at  am et on barrons new force on wall street the ‘family office’ mar   at  pm et on the wall street journal cfo moves fidelity investments universal truckload services sorrento therapeutics apr   at  pm et on the wall street journal cfo moves dream office real estate investment trust sorrento therapeutics seek jun   at  pm et on the wall street journal an asco primer which drug makers are pursuing which kinds of therapies may   at  pm et on the wall street journal sorrento reaches collaboration deal valued at  million mar   at  am et on the wall street journal cfo moves brown shoe company unum group sorrento therapeutics feb   at  pm et on the wall street journal stocks to watch walmart gentiva cisco may   at  am et on the wall street journal recent news other news press releases fda oks sorrentos ind for nonopioid pain candidate resiniferatoxin clinical trial in cancer pain planned shares up  fda oks sorrentos ind for nonopioid pain candidate resiniferatoxin clinical trial in cancer pain planned shares up  jun   at  pm et on seeking alpha sorrento continues rally up  sorrento continues rally up  jun   at  am et on seeking alpha premarket gainers as of  am premarket gainers as of  am jun   at  am et on seeking alpha q sorrento therapeutics inc q sorrento therapeutics inc may   at  pm et on edgar online  edg  q k week in review ping an announces  billion fintechhealthcare vc fund week in review ping an announces  billion fintechhealthcare vc fund may   at  pm et on seeking alpha sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service business sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service business may   at  am et on cnw group marriott international inc mar leads  notable investor filings marriott international inc mar leads  notable investor filings may   at  pm et on investorplacecom insiderinsightscom daily round up  tcbi glv glo glq apr   at  pm et on seeking alpha premarket gainers as of  am apr   at  am et on seeking alpha insiderinsightscom daily round up  wfc merc virt glo dkl apr   at  am et on seeking alpha sorrentos anticea cart candidate shows treatment effect in cea liver cancer patients but survival benefit barely ahead of bayers stivarga and bsc shares ease  apr   at  pm et on seeking alpha k sorrento therapeutics inc mar   at  am et on edgar online  edg  q k celgene shows savvy as gilead keeps backsliding mar   at  am et on barrons new force on wall street the ‘family office’ mar   at  pm et on the wall street journal insider buys shares of sorrento therapeutics feb   at  am et on gurufocuscom hottest services stocks now – ccih fncx llnw matr dec   at  am et on investorplacecom immunotherapy bearish overreaction can create opportunity dec   at  am et on seeking alpha hottest services stocks now – qnst casc fve gvp dec   at  pm et on investorplacecom hottest services stocks now – hmny tgh slp cai dec   at  pm et on investorplacecom biggest movers in services stocks now – vrtu rcii twtr asur dec   at  pm et on investorplacecom todays research reports on stocks to watch sorrento therapeutics and omeros corporation todays research reports on stocks to watch sorrento therapeutics and omeros corporation jul   at  am et on accesswire sorrento therapeutics announced fda authorization of ind to commence clinical trial of rtx in intractable cancer pain sorrento therapeutics announced fda authorization of ind to commence clinical trial of rtx in intractable cancer pain jun   at  pm et on pr newswire  prf semnur pharmaceuticals inc announces successful phase    trial in patients with radicular pain for its lead product sp semnur pharmaceuticals inc announces successful phase    trial in patients with radicular pain for its lead product sp jun   at  am et on pr newswire  prf loncar cancer immunotherapy index conducts semiannual rebalance loncar cancer immunotherapy index conducts semiannual rebalance jun   at  am et on businesswire  bzx sorrento therapeutics announces dismissal of lawsuits sorrento therapeutics announces dismissal of lawsuits jun   at  pm et on pr newswire  prf sorrento therapeutics pain subsidiary scilex pharmaceuticals announces positive data from head to head adhesion study with its lead product ztlido™ sorrento therapeutics pain subsidiary scilex pharmaceuticals announces positive data from head to head adhesion study with its lead product ztlido™ jun   at  am et on pr newswire  prf sorrento therapeutics contributes to the formation of celularity inc sorrento therapeutics contributes to the formation of celularity inc jun   at  am et on pr newswire  prf technical insights on biotech stocks  soligenix sorrento therapeutics alcobra and akebia therapeutics technical insights on biotech stocks  soligenix sorrento therapeutics alcobra and akebia therapeutics jun   at  am et on pr newswire  prf sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service business sorrento therapeutics announces the completion of gmp manufacturing plant in suzhou china to support its growing antibodydrug conjugate adc pipeline and service business may   at  am et on pr newswire  prf sorrento therapeutics announces closing of its acquisition of virttu biologics apr   at  am et on pr newswire  prf sorrento announces closing of public offering of common stock apr   at  pm et on pr newswire  prf sorrento announces pricing of public offering of common stock apr   at  am et on pr newswire  prf sorrento announces proposed public offering of common stock apr   at  pm et on pr newswire  prf global tcell immunotherapy pipeline analysis   clinical trials  results patent designation collaboration and other developments apr   at  pm et on pr newswire  prf sorrento therapeutics anticea cart demonstrates promising clinical activity and safety in phase ib clinical trial apr   at  pm et on pr newswire  prf sorrento and wildcat announce resolution mar   at  am et on pr newswire  prf sorrento therapeutics to present at th annual roth conference mar   at  pm et on pr newswire  prf the life sciences report examines the inclusion of sorrento therapeutics on streetwise reports  smallcap biotech watchlist jan   at  am et on marketwired sorrento subsidiary scilex pharmaceuticals announces key endpoints met in the european union pivotal bioequivalence clinical study for its lead product ztlido™ jan   at  am et on pr newswire  prf loncar cancer immunotherapy index conducts semiannual rebalance dec   at  am et on businesswire  bzx sorrento therapeutics inc sorrento therapeutics inc engages in the research development and manufacture of biopharmaceutical products it focuses on therapies to treat specific stages in the evolution of cancer from elimination to equilibrium and escape which include biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies and antibody drug conjugates the company was founded by henry h ji in  and is headquartered in san diego ca see full profile benzingas top initiations oct   at  am et on benzingacom benzingas top initiations dec   at  am et on benzingacom benzingas top initiations may   at  am et on benzingacom competitors name chg  market cap exelixis inc  b sucampo pharmaceuticals inc cl a  m synergy pharmaceuticals inc  m karyopharm therapeutics inc  m competitor data provided by partner content trending tickers powered by dvax  mo  aks  ssti  fl  advanced search stocks columns authors topics no results found video center learn morestoryful a division of news corp which owns marketwatch is a leading social media services company headquartered in dublin ireland storyful combines world class journalism with industryleading technology to discover verify and acquire original content and provide the ontheground sources news and media organizations need to tell the stories that matter to their audience company  sorrento therapeutics careers contact company sorrento is an antibodycentric clinical stage biopharmaceutical company developing new treatments for cancer inflammation and autoimmune diseases sorrento’s lead products are multiple latestage biosimilar and biobetter antibodies as well as clinical cart therapies targeting solid tumors sorrento has a portfolio of preclinical immunooncology antibody programs and antibody drug conjugates adcs through our subsidiary tnk therapeutics we are developing adoptive immunotherapies utilizing t cell as well as natural killer nk cell  sorrento’s joint venture company la cell is developing cellinternalizing mabs against undruggable intracellular targets menu company our mission our leadership our people board of directors scientific advisors platforms biosimilars immunooncology antibodies cellular therapy cell internalizing antibodies antibody drug conjugates news investors events and presentations stock information corporate governance sec documents careers contact